Ovocalyxin-36 is a pattern recognition protein in chicken eggshell membranes

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Cordeiro, Cristianne M M ^a   Esmaili, Hamed ^a   Ansah, George ^b   Hincke, Maxwell T ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b Hendrix Genetics   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; COMPLEMENTARY DNA; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; LIPOTEICHOIC ACID; MEMBRANE PROTEIN; OVOCALYXIN 36; PEPTIDOGLYCAN RECOGNITION PROTEIN; PROLINE; PROTEIN; SERINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BACTERIAL GROWTH; BINDING AFFINITY; BIRD; EGG SHELL; ESCHERICHIA COLI; GENOTYPE; INNATE IMMUNITY; ION EXCHANGE CHROMATOGRAPHY; LUNG; NONHUMAN; NOSE MUCOSA; OVULATION; PALATE; PATTERN RECOGNITION; PROTEIN PURIFICATION; REPRODUCTION; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STAPHYLOCOCCUS AUREUS;

ACUTE-PHASE PROTEINS; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL INFECTIONS; BLOOD PROTEINS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL MEMBRANE; CHICKENS; CHROMATOGRAPHY, LIQUID; EGG PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; TANDEM MASS SPECTROMETRY; TEICHOIC ACIDS;

EID: 84896704536     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084112     Document Type: Article

References (63)

1. Hincke MT, Nys Y, Gautron J, Mann K, Rodriguez-Navarro AB, et al. (2012) The eggshell: structure, composition and mineralization. Front Biosci 17:1266-1280.
2. Nys Y, Gautron J, Garcia-Ruiz JM, Hincke MT (2004) Avian eggshell mineralization: biochemical and functional characterization of matrix proteins. Comptes Rendus Palevol 3: 549-562. (Pubitemid 39379319)
3. Fernandez MS, Araya M, Arias JL (1997) Eggshells are shaped by a precise spatio-temporal arrangement of sequentially deposited macromolecules. Matrix Biol 16: 13-20. (Pubitemid 27234840)
4. Hincke MT, Gautron J, Panheleux M, Garcia-Ruiz J, McKee MD, et al. (2000) Identification and localization of lysozyme as a component of eggshell membranes and eggshell matrix. Matrix Biology 19: 443-453.
5. Cordeiro CM, Hincke MT (2011) Recent patents on eggshell: shell and membrane applications. Recent Pat Food Nutr Agric 3: 1-8.
6. Arias JL, Fernandez MS, Dennis JE, Caplan AI (1991) Collagens of the chicken eggshell membranes. Connect Tissue Res 26: 37-45.
7. Kodali VK, Gannon SA, Paramasivam S, Raje S, Polenova T, et al. (2011) A novel disulfide-rich protein motif from avian eggshell membranes. PloS One 6: e18187.
8. Gautron J, Hincke MT, Panheleux M, Garcia-Ruiz JM, Boldicke T, et al.(2001) Ovotransferrin is a matrix protein of the hen eggshell membranes and basal calcified layer. Connect Tissue Res 42: 255-267. (Pubitemid 33138548)
9. Gautron J, Murayama E, Vignal A, Morisson M, McKee MD, et al.(2007) Cloning of ovocalyxin-36, a novel chicken eggshell protein related to lipopolysaccharide-binding proteins, bactericidal permeability-increasing proteins, and plunc family proteins. J Biol Chem 282: 5273-5286. (Pubitemid 47093753)
10. Chiang SC, Veldhuizen EJ, Barnes FA, Craven CJ, Haagsman HP, et al. (2011) Identification and characterisation of the BPI/LBP/PLUNC-like gene repertoire in chickens reveals the absence of a LBP gene. Dev Comp Immunol 35: 285-295.
11. Bingle C, Seal R, Craven CJ (2011) Systematic nomenclature for the PLUNC/PSP/BSP30/SMGB proteins as a subfamily of the BPI fold-containing superfamily. Biochem Soc Trans 39: 977-83.
12. Tian X, Gautron J, Monget P, Pascal G (2010) What makes an egg unique? Clues from evolutionary scenarios of egg-specific genes. Biol Reprod 83: 893-900.
13. Krasity BC, Troll JV, Weiss JP, McFallngai MJ (2011) LBP/BPI proteins and their relatives: Conservation over evolution and roles in mutualism. Biochem Soc Trans 39: 1039-1044.
14. Tobias PS, Mathison J, Ulevitch R (1988) A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. J Biol Chem 263: 13479-13481.
15. Yamagata M, Rook SL, Sassa Y, Ma RC, Geraldes P, et al.(2006) Bactericidal/permeability-increasing protein's signaling pathways and its retinal trophic and anti-angiogenic effects. FASEB J 20: 2058-2067. (Pubitemid 44953905)
16. Van der Schaft DW, Toebes EA, Haseman JR, Mayo KH, Griffioen AW (2000) Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells. Blood 96:176e81.
17. Schultz H, Weiss JP (2007) The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease. Clin Chim Acta 384: 12-23. (Pubitemid 47247427)
18. Wiesner J, Vilcinskas A (2010) Antimicrobial peptides. The ancient arm of the human immune system. Virulence 1: 440-464.
19. Gautron J, Réhault-Godbert S, Pascal G, Nys Y, Hincke M (2011) Ovocalyxin-36 and other LBP/BPI/PLUNC-like proteins as molecular actors of the mechanisms of the avian egg natural defences. Biochem Soc Trans 39: 971-976.
20. Hincke MT, Nairn AC (1992). Phosphorylation of elongation factor 2 during Ca (2+)-mediated secretion from rat parotid acini. Biochem J 282: 877-882.
21. Rose-Martel M, Du J Hincke MT (2012) Proteomic analysis provides new insight into the chicken eggshell cuticle. J Proteomics 75: 2697-2706.
22. Keller A, Nesvizhskii AI, Kolker E, Aebersold R (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74:5383-5392. (Pubitemid 35215372)
23. Nesvizhskii AI, Keller A, Kolker E, Aebersold R (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75:4646-4658. (Pubitemid 37082259)
24. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, et al. (2005) Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 4:1265-1272. (Pubitemid 41448714)
25. Haigh B, Hood K, Broadhurst M, Medele S, Callaghan M, et al. (2008) The bovine salivary proteins BSP30a and BSP30b are independently expressed BPI-like proteins with anti-Pseudomonas activity. Mol Immunol 45:1944-1951. (Pubitemid 351226276)
26. Nahid AM, Sugii S (2006) Binding of porcine ficolin-α to lipopolysaccharides from Gram-negative bacteria and lipoteichoic acids from Gram-positive bacteria. Dev Comp Immunol 30:335-343. (Pubitemid 41571273)
27. Kaweewong K, Garnjanagoonchorn W, Jirapakkul W, Roytrakul S (2013) Solubilization and Identification of Hen Eggshell Membrane Proteins During Different Times of Chicken Embryo Development Using the Proteomic Approach. Protein J 4: 297-308.
28. Ahlborn GJ, Clare DA, Sheldon BW, Kelly RW (2006) Identification of eggshell membrane proteins and purification of ovotransferrin and β-NAGase from hen egg white. Protein J 25: 71-81. (Pubitemid 43806850)
29. Levison PR (2003) Large-scale ion-exchange column chromatography of proteins: Comparison of different formats. J Chromatogr B Analyt Technol Biomed Life Sci 790: 17-33.
30. Guérin-Dubiard C, Pasco M, Hietanen A, Quiros del Bosque A, Nau F, et al. (2005) Hen egg white fractionation by ion-exchange chromatography. J Chromatograph A 1090:58-67.
31. Man K (2008) Proteomic analysis of the chicken egg vitelline membrane. Proteomics 8: 2322-2332.
32. Mann K, Maček B, Olsen JV (2006) Proteomic analysis of the acid-soluble organic matrix of the chicken calcified eggshell layer. Proteomics 6: 3801-3810. (Pubitemid 44065158)
33. Rehault-Godbert S, Herve-Grepine V, Gautron J, Cabau C, Nys Y, et al. (2011) Molecules involved in chemical defence of the chicken egg. Improving the safety and quality of eggs and egg products. Volume 1: Egg chemistry, production and consumption. pp. 183-208.
34. Gazzano-Santoro H, Parent JB, Grinna L, Horwitz A, ParsonsT,et al. (1992) High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino terminal fragment to the lipid a region of lipopolysaccha-ride. Infect Immun 60: 4754-4761.
35. Mannion BA, Weiss J, Elsbach P (1990) Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli. J Clin Invest 85: 853-860. (Pubitemid 20087489)
36. Ooi CE, Weiss J, Doerfler ME, Elsbach P (1991) Endotoxin- neutralizing properties of the 25 kd n-terminal fragment and a newly isolated 30 kd cterminal fragment of the 55-60 kd bactericidal/permeability-increasing protein of human neutrophils. J Exp Med 174: 649-655.
37. Shai Y (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1462:55e70.
38. Gorr SU, Abdolhosseini M, Shelar A, Sotsky J (2011) Dual host defence functions of splunc2/psp and synthetic peptides derived from the protein. Biochem Soc Trans 39: 1028-1032.
39. Lukinskiene L, Liu Y, Reynolds SD, Steele C, Stripp BR, et al. (2011) Antimicrobial activity of plunc protects against Pseudomonas aeruginosa infection. J Immunol 187: 382-390.
40. Bartlett J, Gakhar L, Penterman J, Singh P, Mallampalli R, et al. (2011) PLUNC: a multifunctional surfactant of the airways. Biochem Soc Trans 39: 1012-1016.
41. Zhou HD, Li XL, Li GY, Zhou M, Liu HY, et al. (2008) Effect of SPLUNC1 protein on the P. aeruginosa and Epstein-Barr virus. Mol Cell Biochem 309:191-197.
42. Sayeed S, Nistico L, St Croix C, Di YP (2013) Multifunctional role of human SPLUNC1 in P. aeruginosa infection. Infect Immun 81: 285-291.
43. Chu HW, Thaikoottathil J, Rino JG, Zhang G, Wu Q, et al. (2007) Function and regulation of SPLUNC1 protein in Mycoplasma infection and allergic inflammation. J. Immunol. 179: 3995-4002.
44. Levy O (2000) A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein. Antimicrob Agents Chemother 44: 2925-2931.
45. Levy O (2004) Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes. J Leukoc Biol 76: 909-925.
46. Levin M, Quint PA, Goldstein B, Barton P, Bradley J S, et al.(2000) Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group. Lancet 356:961-967.
47. Wittmann I, Schönefeld M, Aichele D, Groer G, Gessner A, et al. (2008) Murine bactericidal/permeability-increasing protein inhibits the endotoxic activity of lipopolysaccharide and gram-negative bacteria. J Immunol 180: 7546-7552.
48. Horwitz AH, Williams RE, Li PS, Nadell R (1999) Bactericidal/ Permeability-Increasing Protein Inhibits Growth of a Strain of Acholeplasma laidlawii and L Forms of the Gram-Positive Bacteria Staphylococcus aureus and Streptococcus pyogenes. Antimicrob Agents Chemother 43: 2314-2316. (Pubitemid 29421224)
49. Srivastava A, Casey H, Johnson N, Levy O, Malley R (2007) Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease. Infect Immun 75: 342-349. (Pubitemid 46047910)
50. Abdolhosseini M, Nandula SR, Song J, Hir H, Gorr SU (2012) Lysine substitutions convert a bacterial-agglutinating peptide into a bactericidal peptide that retains anti-lipopolysaccharide activity and low hemolytic activity. Peptides 35:231-238.
51. Tuan RS, Ono T (1986) Regulation of extraembryonic calcium mobilization by the developing chick embryo. J Embryol Exp Morphol 97: 63-74.
52. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124: 784-801.
53. Schumann RR (2011) Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule. Biochem Soc Trans 39: 989-993.
54. Ghafouri B, Kihlström E, Tagesson C, Lindahl M (2004) PLUNC in human nasal lavage fluid: multiple isoforms that bind to lipopolysaccharide. Biochim Biophys Acta 1699: 57-63. (Pubitemid 38680794)
55. Schro der NWJ, Heine H, Alexander C, Manukyan M, Eckert J, et al. (2004) Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J Immunol 173:2683-2691.
56. Mueller M, Stamme C, Draing C, Hartung T, Seydel U, et al. (2006) Cell activation of human macrophages by lipoteichoicacid is strongly attenuated by lipopolysaccharide-binding protein. J Biol Chem 281:31448-56. (Pubitemid 46041409)
57. Huebner C, Petermann I, Lam WJ, Shelling AN, Ferguson LR (2010) Characterization of single-nucleotide polymorphisms relevant to inflammatory bowel disease in commonly used gastrointestinal cell lines. Inflamm Bowel Dis 2:282-95.
58. Zeng L, Gu W, Zhang AQ, Zhang M, Zhang LY, et al. (2012) A functional variant of lipopolysaccharide binding protein predisposes to sepsis and organ dysfunction in patients with major trauma. Ann Surg 255: 147-157.
59. Barber RC, O'Keefe GE (2003) Characterization of a single nucleotide polymorphism in the lipopolysaccharide binding protein and its association with sepsis. Am J Respir Crit Care Med 167:1316-1320. (Pubitemid 36609713)
60. Chien JW, Boeckh MJ, Hansen JA, Clark JG (2008) Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation. Blood 111:2462-2469. (Pubitemid 351451461)
61. Hubacek JA, Stüber F, Fröhlich D, Book M, Wetegrove S, et al. (2001) Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis. Crit Care Med 29: 557-561. (Pubitemid 32225297)
62. Klein W, Tromm A, Folwaczny C, Hagedorn M, Duerig N, et al. (2005) A polymorphism of the bactericidal/permeability increasing protein (BPI) gene is associated with Crohn's disease. J Clin Gastroenterol 39: 282-283. (Pubitemid 40393241)
63. Yew PY, Mushiroda T, Kiyotani K, Govindasamy GK, Yap LF, et al. (2012) Identification of a functional variant in SPLUNC1 associated with nasopharyngeal carcinoma susceptibility among Malaysian Chinese. Mol Carcino 51: E74-E82.